C3orf41 inhibitors are a class of compounds that interact with the human protein encoded by the C3orf41 gene. This gene is known to be conserved across several species, suggesting that it plays an important role in fundamental biological processes. However, the precise function of the C3orf41 protein remains unclear, and it represents a less-characterized area of cellular biochemistry. The protein encoded by this gene is presumed to have a cellular function that could be pivotal to various molecular pathways. Inhibitors targeting C3orf41 are designed to bind to this protein and modulate its activity, providing insight into its function by observing the outcomes of its inhibition. The development of these inhibitors typically involves the use of high-throughput chemical screens to identify molecules that can specifically bind to C3orf41 and alter its biochemical activity.
The process of discovering C3orf41 inhibitors usually begins with the development of an assay system that can measure the activity of the C3orf41 protein in vitro. Once an assay has been established, large libraries of small molecules can be tested for their ability to affect the activity of C3orf41. Initial hits from these screens are then subjected to further validation to confirm their direct interaction with the protein. This validation often includes the use of biophysical techniques such as surface plasmon resonance (SPR), isothermal titration calorimetry (ITC), or x-ray crystallography to demonstrate that these small molecules specifically bind to C3orf41. Subsequent studies typically focus on understanding the nature of the interaction at a molecular level, including the binding site on the protein, the affinity of the interaction, and the specificity of the inhibitor for C3orf41 as opposed to other proteins.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor that might affect kinase signaling pathways, potentially influencing the expression of other kinases. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
This compound is a p38 MAP kinase inhibitor and could disrupt downstream signaling pathways, potentially affecting kinase expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that may alter various signaling pathways, potentially impacting the expression of certain kinases. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is also a PI3K inhibitor and could affect kinase signaling pathways, influencing kinase expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, rapamycin can alter cell growth pathways and potentially impact the expression of various kinases. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor and could influence the expression of a wide range of kinases. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
Imatinib targets certain tyrosine kinases and may disrupt related signaling pathways, potentially affecting kinase expression. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib is a kinase inhibitor that targets multiple receptors and might influence the expression of various kinases. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Sunitinib is a receptor tyrosine kinase inhibitor and could possibly affect the expression levels of certain kinases. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Palbociclib inhibits CDK4/6 and might indirectly influence the expression of kinases through cell cycle regulation. | ||||||